Print Page   |   Contact Us   |   Sign In   |   Join iBIO
News & Press: iBIO Institute News

PROPEL Awards Grants for AdvaMed 2013 to Early-State Life Sciences Companies

Monday, July 29, 2013  
Share |

The PROPEL Center of the iBIO Institute, dedicated to increasing the number and success rate of early-stage life sciences companies in Illinois, announced today that it has awarded thirteen grants to help local entrepreneurs attend AdvaMed 2013 in Washington DC. AdvaMed 2013 is the leading med-tech conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking.

 

PROPEL awarded six of these grants to help Illinois early-stage life sciences companies participate in the conference’s Company Presentations. These PROPEL grant recipients included Advanced Cooling Therapy, Diagnostic Photonics, Endotronix, Ohmx, Opsys, and TheraBionic. 

 

"AdvaMed is a great forum to engage with a broad spectrum of the best of the medical device industry,” said Endotronix CEO Harry Rowland. "This PROPEL award will catalyze our growth, allowing Endotronix to communicate our milestones and rapid development to an important network of decision makers at an exciting time for our company."

 

"Many of our early-stage life sciences companies can benefit from attending AdvaMed 2013, but often the cost of registration can be prohibitive for these startups,” said Barbara Goodman, senior vice president of PROPEL. "With these awards, and with AdvaMed coming to Chicago in 2014, this is a great opportunity to showcase Illinois’ outstanding medical devices and medical technologies and our thriving startup community.”

 

For more information on PROPEL or the iBIO Institute, visit www.ibioinstitute.org.

 

For more information on AdvaMed 2013, visit www.advamed2013.com.

 

About PROPEL

PROPEL is a group of programs aimed at increasing the number and success rate of early-stage life sciences companies in Illinois. PROPEL helps guide the development of formation-stage and early-stage life sciences companies by providing entrepreneurs with access to specialized resources and expertise to prepare them for early-stage funding. PROPEL is a Center of the iBIO Institute. To learn more about PROPEL and its programs, visit www.ibiopropel.org.

 

About iBIO Institute

The mission of the iBIO Institute is to orchestrate business leadership in delivery of world-class educational programs and job-creating new technology ventures. The Institute’s EDUCATE Center delivers science and math programs for teachers and students, thereby inspiring the next generation of innovators and helping restore America’s leadership in technology education. The Institute’s PROPEL Center increases the number and success rate of early-stage life sciences companies in Illinois. To learn more about iBIO Institute and its programs, visit www.ibioinstitute.org.


Association Management Software Powered by YourMembership.com®  ::  Legal